Literature DB >> 28236062

Bone mineral density and insulin-like growth factor-1 in children with spastic cerebral palsy.

H Nazif1, R Shatla2, R Elsayed3, E Tawfik4, N Osman5, S Korra6, A Ibrahim1.   

Abstract

BACKGROUND: Children with cerebral palsy (CP) have significant decrease linear growth rate and low bone mineral density (BMD). AIMS: This study is to evaluate BMD in children with CP and its relation to the levels of insulin-like growth factor-1 (IGF-1). SUBJECTS AND METHODS: This cross-sectional study was carried out on 58 children suffering from spastic CP with the age range 4-12 years compared to 19 controls. All assessed by dual energy x-ray absorptiometry (DXA) to measure BMD, serum level of IGF-1, and serum vitamin D. The patients were classified according to their GMFCS.
RESULTS: Fractures were reported in seven (12.1%) of cases. Our study demonstrated that, IGF-1 level and BMD decrease in correlation with the severity of CP. IGF-1correlates positively with serum vitamin D, BMI, and BMD. CP children with severe GMFCS level or who use anticonvulsive drugs are at a high risk for low BMD and low levels of IGF-1.
CONCLUSION: Both BMD and IGF-1 were significantly in low children with spastic CP; IGF-1 negatively correlates with the severity of osteopenia in children with spastic. Children with CP who are not independently ambulant or with severe GMFCS level or who use anticonvulsive drugs are at a high risk for developing low BMD.

Entities:  

Keywords:  Bone mineral density; IGF-1; Spastic CP; Vitamin D

Mesh:

Substances:

Year:  2017        PMID: 28236062     DOI: 10.1007/s00381-017-3346-9

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  25 in total

1.  Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care.

Authors:  M Jekovec-Vrhovsek; A Kocijancic; J Prezelj
Journal:  Dev Med Child Neurol       Date:  2000-06       Impact factor: 5.449

2.  Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences.

Authors:  S Mohan; D J Baylink
Journal:  J Endocrinol       Date:  2005-06       Impact factor: 4.286

3.  Bone mineral density in children with cerebral palsy.

Authors:  H A Tasdemir; M Buyukavci; F Akcay; P Polat; A Yildiran; C Karakelleoglu
Journal:  Pediatr Int       Date:  2001-04       Impact factor: 1.524

4.  Apparent growth hormone deficiency in children with cerebral palsy.

Authors:  S J Coniglio; R D Stevenson; A D Rogol
Journal:  Dev Med Child Neurol       Date:  1996-09       Impact factor: 5.449

Review 5.  Bone health in cerebral palsy: who's at risk and what to do about it?

Authors:  Christine Murray Houlihan
Journal:  J Pediatr Rehabil Med       Date:  2014

6.  Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy.

Authors:  Richard C Henderson; Robert K Lark; Matthew J Gurka; Gordon Worley; Ellen B Fung; Mark Conaway; Virginia A Stallings; Richard D Stevenson
Journal:  Pediatrics       Date:  2002-07       Impact factor: 7.124

7.  Prevalence of reduced bone mass in children and adults with spastic quadriplegia.

Authors:  Wilson King; Ronald Levin; Rosemary Schmidt; Alan Oestreich; James E Heubi
Journal:  Dev Med Child Neurol       Date:  2003-01       Impact factor: 5.449

Review 8.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

9.  Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture.

Authors:  Sarah D Berry; Elizabeth J Samelson; Michael J Pencina; Robert R McLean; L Adrienne Cupples; Kerry E Broe; Douglas P Kiel
Journal:  JAMA       Date:  2013-09-25       Impact factor: 56.272

10.  Body mass index in ambulatory cerebral palsy patients.

Authors:  Brian T Feeley; Kiran Gollapudi; Norman Y Otsuka
Journal:  J Pediatr Orthop B       Date:  2007-05       Impact factor: 1.041

View more
  6 in total

Review 1.  Potential applications for rhIGF-I: Bone disease and IGFI.

Authors:  Marisol Bahamonde; Madhusmita Misra
Journal:  Growth Horm IGF Res       Date:  2020-03-23       Impact factor: 2.372

2.  5-year fracture risk among children with cerebral palsy.

Authors:  Daniel G Whitney
Journal:  Pediatr Res       Date:  2022-07-19       Impact factor: 3.953

3.  Associations of Circulating Insulin-Growth Factor-1 With Cognitive Functions and Quality of Life Domains in Ambulatory Young Adults With Cerebral Palsy: A Pilot Study.

Authors:  Ted Kheng Siang Ng; Patricia C Heyn; Alex Tagawa; Christina Coughlan; James J Carollo
Journal:  Front Neurol       Date:  2022-06-27       Impact factor: 4.086

Review 4.  Bone Marrow Fat Physiology in Relation to Skeletal Metabolism and Cardiometabolic Disease Risk in Children With Cerebral Palsy.

Authors:  Daniel G Whitney; Mark D Peterson; Maureen J Devlin; Michelle S Caird; Edward A Hurvitz; Christopher M Modlesky
Journal:  Am J Phys Med Rehabil       Date:  2018-12       Impact factor: 2.159

Review 5.  Vitamin D and growth hormone in children: a review of the current scientific knowledge.

Authors:  Susanna Esposito; Alberto Leonardi; Lucia Lanciotti; Marta Cofini; Giulia Muzi; Laura Penta
Journal:  J Transl Med       Date:  2019-03-18       Impact factor: 5.531

Review 6.  Vitamin D deficiency in children with cerebral palsy: A narrative review of epidemiology, contributing factors, clinical consequences and interventions.

Authors:  Kamel Awadh Alenazi
Journal:  Saudi J Biol Sci       Date:  2021-12-16       Impact factor: 4.052

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.